Logo for Theriva Biologics Inc

Theriva Biologics Investor Relations Material

Latest events

Logo for Theriva Biologics Inc

Q4 2023

Theriva Biologics
Logo for Theriva Biologics

Q4 2024

6 Mar, 2025
Logo for Theriva Biologics

Q3 2024

12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Theriva Biologics Inc

Access all reports
Theriva Biologics Inc. is a clinical-stage biotechnology company developing novel therapies for cancer and other serious diseases. The company focuses on oncolytic viruses and microbiome-based therapies designed to enhance the effectiveness of existing treatments and improve patient outcomes. Theriva’s pipeline includes investigational products targeting solid tumors, gastrointestinal diseases, and other conditions. The company is headquartered in Rockville, Maryland, and its shares are listed on the NYSE.